Acute Disseminated Encephalomyelitis Post COVID-19 Pneumonia

Abdulaziz A Alqarni1,2, Danya A Aljafari1,2, Faris A Alzahrani3

  • 1College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, SAU.

Cureus
|March 9, 2023
PubMed

Insights

Acute disseminated encephalomyelitis (ADEM) can occur after infections like COVID-19. This case highlights ADEM in an elderly patient with coronavirus disease pneumonia, presenting with neurological symptoms and brain lesions.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Neuroimmunology

Background:

  • Acute disseminated encephalomyelitis (ADEM) is an inflammatory demyelinating disorder of the central nervous system.
  • ADEM is typically monophasic and often follows an infection or immunization, presenting with neurological symptoms.
  • COVID-19 has been associated with various neurological complications, including inflammatory conditions.

Observation:

  • An 80-year-old woman with COVID-19 pneumonia developed sudden decreased consciousness, focal seizure, and right-sided weakness.
  • Brain MRI revealed multifocal hemorrhagic lesions with surrounding edema, indicative of ADEM.
  • Electroencephalogram (EEG) showed moderate generalized encephalopathy.

Findings:

  • The patient's presentation and imaging findings were consistent with ADEM secondary to coronavirus disease.
  • Treatment with pulse steroids and plasma exchange did not prevent clinical deterioration.
  • The patient required inotropic support and ultimately expired.

Implications:

  • This case underscores the potential for ADEM development in elderly patients with severe COVID-19.
  • It highlights the challenges in managing ADEM, particularly in older individuals with co-existing critical illness.
  • Further research is needed to understand the neuroinflammatory mechanisms of COVID-19 and optimize ADEM treatment strategies.